Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Nissim Mashiach



Mr. Mashiach served as President and Chief Executive Officer of Macrocure Ltd. from June 2012 to January 2017. Macrocure was a Nasdaq listed biotechnology company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds. From 2009 to 2012, he served as General Manager at Ethicon, a Johnson & Johnson company. Prior to Ethicon, he served as President and Chief Operating Officer at Omrix Biopharmaceuticals, Inc., a company acquired by Johnson & Johnson in 2008. Prior to Omrix, Mr. Mashiach held leadership positions at several pharmaceutical companies. He holds an MBA from the University of Manchester (Manchester, England), an MPharmSc from the Hebrew University (Jerusalem, Israel), and a B.Sc, Chemical Engineering from the Technion-Israel Institute of Technology (Haifa, Israel).

Research Interest


Global Experts from Israel

Global Experts in Subject

Share This Profile
Recommended Conferences